Powered by

Stock Monthly: Antibe Therapeutics (ATE:70.0c) soars 15%, 2 months' volume in a month Thursday April 30, 2020 17:00 EDT

Apr 30, 2020 - News Bites Canadian Markets
Board and Executive Moves-Financial Results

CANADIAN MONTHLY STOCK REPORT

Antibe Therapeutics (TSXV:ATE), Canada's 7th largest Biotechnology company by market cap, has soared 9.0c (or 14.8%) in the past month to close at 70.0c on Thursday April 30. The volume was 2 times average monthly trading of 22 million shares. Compared with the S&P/TSX 60 Index which rose 71.7 points (or 8.8%) in the month, this represented a relative price increase of 6%. In the past month the market cap has jumped CAD26.5 million (US$36.7 million).

Price Change % 1-month 6-month 3-year ATE 14.8% 37.3% 311.8% Biotechnology sector 10.2% 6.7% 71.8% S&P/TSX 60 Index 8.8% -9.6...